Deltex Medical Group PLC Director dealing and issue of equity (5756E)

TIDMDEMG

RNS Number : 5756E

Deltex Medical Group PLC

12 February 2018

12 February 2018

Deltex Medical Group plc

("Deltex Medical", "Deltex" or "the Company")

Director dealing and issue of equity

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM") announces that it has issued 800,000 new Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of options by Ewan Phillips, Chief Executive Officer, granted under the Company's Enterprise Management Incentive Share Option Scheme. The options had an exercise price of 1 pence per share and the notice of exercise was received on 9 February 2018.

Application has been made for the 800,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on 15 February 2018. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

Following Admission, the total number of Ordinary Shares in issue with voting rights will be 490,663,367 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Confirmation of Director's shareholding

Following the above purchase, Ewan Phillips owns 4,682,111 ordinary shares representing 0.95% per cent. of the Company's issued share capital.

For further information, please contact:-

 
 Deltex Medical Group            01243 774 837 
  plc                             [e-mail] 
 Nigel Keen, Chairman 
 Ewan Phillips, Chief 
  Executive 
 Jonathan Shaw, Group 
  Finance Director 
 
 Nominated Adviser & 
  Broker 
 Arden Partners plc              020 7614 5900 
 Chris Hardie 
  Ciaran Walsh 
 
 Joint Broker 
 Turner Pope Investments         0203 621 4120 
  (TPI) Ltd                       [e-mail] 
 Andy Thacker 
 
   Financial Public Relations 
 IFC Advisory Ltd                0203 053 8671 
 Tim Metcalfe 
  Graham Herring 
  Heather Armstrong 
 

PDMR Notification Forms:

The notifications below are made in accordance with the requirements of MAR.

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                             Ewan Phillips 
---  -------------------------------  --------------------------- 
 2.   Reason for the Notification 
---  ------------------------------------------------------------ 
 a)   Position/status                  Chief Executive 
---  -------------------------------  --------------------------- 
 b)   Initial notification/amendment   Initial notification 
---  -------------------------------  --------------------------- 
 3.   Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                             Deltex Medical Group plc 
---  -------------------------------  --------------------------- 
 b)   LEI                              N/A 
---  -------------------------------  --------------------------- 
 4.   Details of the transaction(s):section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and 
       (iv)each place where transactions have been 
       conducted 
---  ------------------------------------------------------------ 
 a)   Description of                   Ordinary shares of 1 pence 
       the Financial instrument,        each 
       type of instrument 
---  -------------------------------  --------------------------- 
      Identification                   GB00B95L0551 
       code 
---  -------------------------------  --------------------------- 
 b)   Nature of the Transaction        Exercise of share options 
---  -------------------------------  --------------------------- 
 c)   Price(s) and volume(s)            Price(s)   Volume(s) 
                                        ---------  ---------- 
                                         1p         800,000 
                                        ---------  ---------- 
---  -------------------------------  --------------------------- 
 d)   Aggregated information           N/A (Single transaction) 
       Aggregated volume 
       Price 
---  -------------------------------  --------------------------- 
 e)   Date of the transaction          15 February 2018 
---  -------------------------------  --------------------------- 
 f)   Place of the transaction         London Stock Exchange, AIM 
---  -------------------------------  --------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFFAFSIFLIT

(END) Dow Jones Newswires

February 12, 2018 04:30 ET (09:30 GMT)